Amylyx Pharmaceuticals, Inc. share price logo

Amylyx Pharmaceuticals, Inc. Share Price

NASDAQ: AMLX

Small Cap

$13.22

+0.45

(+3.52%)

Live

as on

Amylyx Pharmaceuticals, Inc. Stock Performance

as on September 19, 2025 at 12:43 am IST

  • Day's Low

    Day's High

    $12.62
    $13.33
    downward going graph

    4.54%

    Downside

    0.83%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.6
    $13.1
    downward going graph

    80.33%

    Downside

    -0.91%

    Upside

    downward going graph

Amylyx Pharmaceuticals, Inc. share price movements today

Previous Close
$12.77
Open
$12.92
Volume
1.1M
Day's Low - High
$12.62 - $13.33
52 Week Low - High
$2.6 - $13.1

Amylyx Pharmaceuticals, Inc. Historical Returns

1 Month Return
+ 59.82 %
3 Month Return
+ 150.39 %
1 Year Return
+ 343.4 %
3 Year Return
-56.54 %
5 Year Return
0 %

Amylyx Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Check Amylyx Pharmaceuticals, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.3B

EPS (TTM)

-1.7297

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.87

Industry PE ratio

-3.9415151515151514

P/B Ratio

0

PEG Ratio

0

EBITDA

-196.3M

Revenue (TTM)

-249.0K

Profit Margin

0.00%

Return On Equity TTM

19083400.00%

Amylyx Pharmaceuticals, Inc. Stock Valuation

Track how Amylyx Pharmaceuticals, Inc. P/E has moved over time to understand its valuation trends.

Amylyx Pharmaceuticals, Inc. in the last 5 years

  • Overview

  • Trends

Lowest (21.90x)

December 31, 2023

Industry (-3.94x)

September 18, 2025

Today (-0.87x)

September 18, 2025

Highest (23.35x)

March 31, 2024

LowHigh

Today’s Price to Earnings Ratio: -0.87x

Amylyx Pharmaceuticals, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Amylyx Pharmaceuticals, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$1.3BNA-0.870.00%
BUY$60.5B241.54%-505.15-12.96%
NA$38.7BNANA-3.89%
BUY$99.3B45.88%27.5631.86%
BUY$60.9B5.45%14.4931.37%

Stock Returns calculator for Amylyx Pharmaceuticals, Inc. Stock including INR - Dollar returns

The Amylyx Pharmaceuticals, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Amylyx Pharmaceuticals, Inc. investment value today

Current value as on today

₹4,63,981

Returns

₹3,63,981

(+363.98%)

Returns from Amylyx Pharmaceuticals, Inc. Stock

₹3,59,028 (+359.03%)

Dollar Returns*

₹4,953 (+4.95%)

Analyst Recommendation on Amylyx Pharmaceuticals, Inc. Stock

Based on 13 analysts

BUY

53.85%

Buy

46.15%

Hold

0.00%

Sell

Based on 13 analysts, 53.85% of analysts recommend a 'BUY' rating for Amylyx Pharmaceuticals, Inc.. Average target price of $14.88

Amylyx Pharmaceuticals, Inc. Share Price Target

Get share price movements and forecasts by analysts on Amylyx Pharmaceuticals, Inc..

What analysts predicted

11.16%UPSIDE

Target Price

$14.88

Current Price

$13.22

Analyzed by

13 Analysts

Target

$14.88

Amylyx Pharmaceuticals, Inc. target price $14.88, a slight upside of 11.16% compared to current price of $13.22. According to 13 analysts rating.

Amylyx Pharmaceuticals, Inc. Stock's Interest Amongst Investors

Search interest for Amylyx Pharmaceuticals, Inc. Stock has increased by 529% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:529% versus previous 30 day period

Amylyx Pharmaceuticals, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
71
98
102
108
88
-1
0
0
-
-
Gross Profit
66
92
97
99
-28
-8
0
0
-
0
Operating Income
-2
20
18
1
-122
-53
-75
-40
-37
-42
EBITDA
-1
20
19
2
-121
-53
-75
-40
-37
-41
Interest Expense
3
-
-
3
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
1
24
22
6
-118
-72
-72
-38
-35
-41
Income Tax Expense
0
1
1
1
0
-
-72
0
-
-
Net Income
1
22
20
4
-118
-72
-72
-37
-35
-41
Net Profit Margin
2.20%
22.47%
20.35%
4.36%
-134.01%
7106.55%
-17476.92%
5646.02%
0.00%
0.00%

Amylyx Pharmaceuticals, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
1
0
0
22
380
87
Gross Profit
-10
-23
0
19
355
-37
Operating Income
-13
-39
-82
-201
38
-314
EBITDA
1
-39
-82
-200
39
-290
Interest Expense
1
2
0
4
-
-
Depreciation
-
0
0
0
1
0
Income Before Tax
-13
-42
-87
-197
54
-302
Income Tax Expense
1
2
0
0
5
0
Net Income
-14
-44
-87
-198
49
-301
Net Profit Margin
-1038.99%
-6898.00%
-30834.74%
-892.38%
12.94%
-345.36%

Amylyx Pharmaceuticals, Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
22
20
4
-118
-72
-72
-37
-35
-41
Operating Cash Flow
8
-5
13
0
-66
-41
-59
-39
-25
Investing Cash Flow
123
-108
20
0
-28
38
64
-43
22
Financing Cash Flow
1
0
0
0
0
0
0
65
0
Change in Cash
133
-112
34
0
-95
-1
5
-17
-1

Amylyx Pharmaceuticals, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-42
-87
-198
49
-301
Operating Cash Flow
-36
-74
-179
11
-167
Investing Cash Flow
0
-46
-238
92
75
Financing Cash Flow
46
158
431
3
0
Change in Cash
9
37
12
107
-92

Global Institutional Holdings in Amylyx Pharmaceuticals, Inc.

Funds
Holdings
Perceptive Advisors LLC
8.83%
TCG Crossover Management, LLC
6.67%
Adage Capital Partners Gp LLC
6.39%
Vanguard Group Inc
4.62%
Millennium Management LLC
3.46%

Insights on Amylyx Pharmaceuticals, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, AMLX has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, AMLX stock has moved up by 7.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 168.0%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 416.0K → -665.0K (in $), with an average decrease of 259.9% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -35.90M → -41.44M (in $), with an average decrease of 15.4% per quarter

About Amylyx Pharmaceuticals, Inc.

Amylyx Pharmaceuticals, Inc is a biopharmaceutical company headquartered in Cambridge, Massachusetts. Amylyx is best known for AMX0035, an experimental therapy for amyotrophic lateral sclerosis.
OrganisationAmylyx Pharmaceuticals, Inc.
Headquarters43 Thorndike Street, Cambridge, MA, United States, 02141
IndustryServices
CEOMr. Joshua B. Cohen
E-voting on sharesClick here to vote

Key Management of Amylyx Pharmaceuticals, Inc.

Name

Title

Mr. James M. Frates M.B.A.

Chief Financial Officer

Ms. Gina M. Mazzariello J.D.

Chief Legal Officer & General Counsel

Ms. Lindsey Allen

Head of Investor Relations & Communications

Ms. Linda A. Arsenault

Chief Human Resources Officer

Ms. Tammy Sarnelli

Global Head of Regulatory Affairs

Mr. Joshua B. Cohen

Co-Founder, Co-CEO & Director

Mr. Justin B. Klee

Co-Founder, Co-CEO & Director

Dr. Jamie Timmons

Head of Global Medical Strategy & Communications

Mr. Tom Holmes

Chief Technical Operations Officer

Dr. Machelle Manuel Ph.D.

VP & Head of Global Medical Affairs

FAQs

What is Amylyx Pharmaceuticals, Inc. share price today?

Amylyx Pharmaceuticals, Inc. share price today is $13.22 as on . Amylyx Pharmaceuticals, Inc. share today touched a day high of $13.33 and a low of $12.62.

What is the 52 week high and 52 week low for Amylyx Pharmaceuticals, Inc. share?

Amylyx Pharmaceuticals, Inc. share touched a 52 week high of $13.1 on and a 52 week low of $2.6 on . Amylyx Pharmaceuticals, Inc. stock price today i.e. is trending at $13.22,which is -0.92% down from its 52 week high and 408.46% up from its 52 week low.

What is Amylyx Pharmaceuticals, Inc.'s market capitalisation today?

Amylyx Pharmaceuticals, Inc. market capitalisation is $0.00T as on .

How to invest in Amylyx Pharmaceuticals, Inc. Stock (AMLX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Amylyx Pharmaceuticals, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Amylyx Pharmaceuticals, Inc. Shares that will get you 0.1135 shares as per Amylyx Pharmaceuticals, Inc. share price of $13.22 per share as on September 19, 2025 at 12:43 am IST.

What is the minimum amount required to buy Amylyx Pharmaceuticals, Inc. Stock (AMLX) from India?

Indian investors can start investing in Amylyx Pharmaceuticals, Inc. (AMLX) shares with as little as ₹88.114 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Amylyx Pharmaceuticals, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Amylyx Pharmaceuticals, Inc. share’s latest price of $13.22 as on September 19, 2025 at 12:43 am IST, you will get 0.7564 shares of Amylyx Pharmaceuticals, Inc.. Learn more about fractional shares .